Thu. 25 Apr 2024, 4:16pm ET
Benzinga
Earnings, Earnings Beats, News
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. The company reported quarterly sales of $1.598 billion which beat the analyst consensus estimate of $1.569 billion by 1.85 percent. This is a 9.45 percent increase over sales of $1.460 billion the same period last year.